|
TAAP (The Autism Autoimmunity Project) "TAAP into the Truth!" |
|
Submitted to: AutismAutoimmunityProject web site. Largely taken from talk prepared June 2001.
Stealth-Adapted Viruses and the Epidemic of Autism Introduction Autism is a diagnostic label applied to neurological disorders of early childhood onset. It manifests as deficits in communication and in other social interactive skills. Considerable variability exists in the severity of disease in autistic patients, with somewhat arbitrary distinctions between autism and childhood disintegration disorder at one end and delayed normal development at the other extreme. Autistic patients will commonly show a wider variety of clinical manifestations than implied by a single diagnostic label. While many millions of dollars have been spent on autism-related research, only a few studies have addressed autism as a viral illness. This is in part due to the lack of infectious disease expertise by the majority of health care workers involved with autistic children. It also reflects an unwillingness of Public Health officials to openly address this important subject. Arguably, to do so would expose questionable decisions made regarding the prior use of potentially contaminated viral vaccines. Stealth-Adapted Viruses I have proposed that autism is primarily a prenatal viral infection that involves the brain and that occurs in a genetically predisposed individual. The infection renders the person susceptible to further brain damage from vaccines and other environmental and/or auto-immune factors. The types of viruses involved are notable because they do not ordinarily provoke an inflammatory reaction. They have, accordingly, been termed “stealth-adapted” viruses. They can, however, be detected using specialized virus culture methods as described in the journal “Experimental and Molecular Pathology,” Volume 74: pages 210-223, 2003. Polio Vaccine Origin of a Stealth-Adapted Virus The most extensively studied stealth-adapted virus arose from an African green monkey simian cytomegalovirus (SCMV). African green monkeys were used to grow polio virus vaccines. DNA from this virus was detected by Government officials in several licensed polio virus vaccines used in the United States with similar findings reported from England. Although the investigators failed to grow SCMV from the contaminated vaccines, this may simply reflect the limited culture methods used. Detection of a Stealth Virus Infection I have documented that routine neurological examination does not necessarily detect clinical signs of a stealth virus brain infection. Culture methods still provide the most sensitive assay for these viruses. Stealth-adapted viruses were readily detectable in the majority of autistic children that I had previously examined. My laboratory is no longer performing this test. Nevertheless, in my opinion parents have the right to question Public Health authorities as to whether their autistic child is infected with a stealth-adapted virus. To be convinced otherwise, should require a negative culture using a culture method suitable for demonstrating stealth-adapted viruses.
Alternative Cellular Energy Pigments (ACE-Pigments) Important new insights have arisen concerning the mechanism whereby cells continue to survive in spite of being stealth virus infected. The cells acquire a novel source of cellular energy via what have been called alternative cellular energy pigments (ACE-pigments). These mineral-containing pigments can respond to various sources of physical and chemical stimulation. The existence of ACE-pigments can also help explain the findings of various heavy metals and toxic substances in the blood and hair of autistic children. S3Support Public Health disregard for a potential infectious cause of autism and other illnesses that are becoming increasing prevalent in our society should not continue. This situation can be corrected by a sufficiently vocal public opinion based on a reasonable interpretation of the available scientific knowledge. A membership based web site has been established at www.S3Support.com It will serve as a mechanism to focus public opinion and to provide useful scientific and historical information. It should also provide a knowledgeable patient pool for clinical trials to evaluate the usefulness of energy-based and other therapeutic modalities in stealth virus infected patients. Readers of this report are invited to go to the web site and are particularly encouraged to become supportive members. Additional inquiries can be sent to Dr. W. John Martin at S3Support@mail.com |
|
|